Adherence in 2025: How Close Are We to Finally Solving the Retinal Treatment Burden?
“Every time I miss a shot, I see less. But I also might lose my job if I go. What…
FDA Approves Roche’s Susvimo for Diabetic Retinopathy
Genentech/Roche’s sustained release anti-VEGF eye implant provides a treatment option with reduced frequency for diabetic retinopathy. Sustained release anti-VEGF is…
latest posts